Preoperative lymph-node enlargement is associated with favorable survival for patients with pathological stage II colorectal cancer
Surgery Today · 2026-11 · 56 (11) · 3079-3089
DOI: 10.1007/s00595-026-03440-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, online erschienen am 12.08.2026. Verfasst von Emi Ota und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Fujisawa City Hospital, Fujisawa, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Lymph Nodes, Adenocarcinoma. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The importance of preoperative lymph-node enlargement as a prognostic factor for patients with colorectal cancer remains unclear because of inconsistent staging and size criteria. We conducted this study to evaluate its clinical impact, using a standardized definition for pathological stage II colorectal cancer.
Methods
The subjects of this retrospective study were patients with pathological stage II colorectal adenocarcinoma, who underwent curative resection between January 2009 and December 2020. Patients were categorized based on preoperative lymph-node enlargement, defined as a short-axis diameter ≥5 mm on imaging. Independent risk factors for 5-year overall survival (OS) and relapse-free survival (RFS) were investigated.
Results
A total of 562 patients were included (185 without and 377 with enlarged lymph nodes), and the median follow-up period was 61.8 months. Multivariate analysis identified that preoperative hemoglobin level < 12 g/dL (hazard ratios (HRs) = 1.937, 95% confidence interval (CI) = 1.181–3.175, p = 0.009) and preoperative bowel obstruction (hazard ratios (HRs) = 2.060, 95% confidence interval (CI) = 1.066–3.979, p = 0.031) were independent factors for poor OS. Conversely, lymph node enlargement was independently associated with favorable OS (HRs = 0.503, 95% CI, 0.316–0.801, p = 0.004). Pathological T4 stage was an independent factor for poor RFS (HRs = 2.973, 95% CI = 1.752–5.044, p < 0.001).
Conclusions
Preoperative lymph-node enlargement predicts favorable OS for patients with pathological stage II colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Fujisawa City Hospital, Fujisawa, Japan.
- Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, 4-57, Urafune-cho, Minami-ku, Yokohama-shi, 232-0024, Japan.
- Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, 4-57, Urafune-cho, Minami-ku, Yokohama-shi, 232-0024, Japan. ozawama@yokohama-cu.ac.jp.
- Department of Gastroenterological Surgery, Yokohama City University Graduate school of Medicine, Yokohama, Japan.
- Department of Surgery, Yokosuka Kyosai Hospital, Yokosuka, Japan.
Zitieren
APA
Ota, E., Ozawa, M., Yamagishi, S., Nakagawa, K., Mori, K., Den, K., Suwa, H., & Endo, I. (2026). Preoperative lymph-node enlargement is associated with favorable survival for patients with pathological stage II colorectal cancer. Surgery Today, 56(11), 3079-3089. https://doi.org/10.1007/s00595-026-03440-8
Vancouver
Ota E, Ozawa M, Yamagishi S, Nakagawa K, Mori K, Den K, et al. Preoperative lymph-node enlargement is associated with favorable survival for patients with pathological stage II colorectal cancer. Surgery Today. 2026;56(11):3079-3089. doi:10.1007/s00595-026-03440-8
BibTeX
@article{Ota2026,
author = {Ota, Emi and Ozawa, Mayumi and Yamagishi, Shigeru and Nakagawa, Kazuya and Mori, Koichi and Den, Kanechika and Suwa, Hirokazu and Endo, Itaru},
title = {Preoperative lymph-node enlargement is associated with favorable survival for patients with pathological stage II colorectal cancer},
journal = {Surgery Today},
year = {2026},
volume = {56},
number = {11},
pages = {3079--3089},
doi = {10.1007/s00595-026-03440-8}
}
EUVIMED